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Abstract
Bone deterioration is a challenge in long-term spaceflight with significant connections to pa-
tients experiencing disuse bone loss. Prolonged unloading and radiation exposure, defining
characteristics of space travel, have both been associated with changes in inflammatory
signaling via IL-6 class cytokines in bone. While there is also evidence for perturbed IL-6
class signaling in spaceflight, there has been scant examination of the connections between
microgravity, radiation, and inflammatory stimuli in bone. Our lab and others have shown
that the IL-6 class cytokine oncostatin M (OSM) is an important regulator of bone remodel-
ing. We hypothesize that simulated microgravity alters osteoblast OSM signaling, contribut-
ing to the decoupling of osteolysis and osteogenesis in bone homeostasis. To test this
hypothesis, we induced OSM signaling in murine MC3T3-E1 pre-osteoblast cells cultured in
modeled microgravity using a rotating wall vessel bioreactor with and without exposure to
radiation typical of a solar particle event. We measured effects on inflammatory signaling,
osteoblast activity, and mineralization. Results indicated time dependent interactions
among all conditions in the regulation of IL-6 production. Furthermore, OSM induced the
transcription of OSM receptor ß, IL 6 receptor α subunits, collagen α1(I), osteocalcin, scler-
ostin, RANKL, and osteoprotegerin. Measurements of osteoid mineralization suggest that
the spatial organization of the osteoblast environment is an important consideration in un-
derstanding bone formation. Taken together, these results support a role for altered OSM
signaling in the mechanism of microgravity-induced bone loss.
Introduction
Deteriorating bone health is a substantial barrier to human exploration deeper into the solar
system [1]. Each month in space, astronauts lose approximately 1% of the mineral density in
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their weight-bearing bones [2–5]. Travel to Mars or near-Earth asteroids could last two years
or more, greatly extending the astronauts’ exposure to the risks of spaceflight most relevant to
bone health: microgravity and ionizing radiation. Galactic cosmic rays (GCR) and solar particle
events (SPE) become important sources of radiation to astronauts, where they may be exposed
to more than 2 Gy of radiation [6,7]. These doses are comparable to those used in cancer radio-
therapy to kill tumor cells. There are also recognized clinical parallels between spaceflight bone
loss and disuse osteoporosis, a common complication of inactivity from bed rest, immobiliza-
tion, or sedentary lifestyle{FormattingCitation}. To date, efforts to counter microgravity-medi-
ated bone demineralization have focused on resistive exercise and nutrition with limited
success [2–4,11]. Taken together, these facts imply that pharmacological countermeasures to
bone loss will likely be required for exploration deeper into the solar system; however, an in-
creased understanding of relevant molecular pathways is needed to identify possible targets
for intervention.
The bone remodeling cycle is a multicellular process where bone is constantly broken down
and replaced [12–16]. Bone is calcified extracellular matrix (ECM) produced by osteoblasts,
whose differentiation from mesenchymal stem cells (MSC) is determined primarily by the
transcription factor RUNX2 [17]. After proliferation and additional maturation that is marked
by the transcription factor osterix[18], the osteoblast will produce osteoid, the organic compo-
nent of bone ECM that is primarily composed of type I collagen. Additional factors such as
osteocalcin regulate the mechanical and chemical properties of the bone [19]. As the ECMma-
tures, osteoblasts become encased and terminally differentiate into osteocytes [20]. An impor-
tant function of the osteocyte is to limit the excessive formation of bone, largely through the
production of sclerostin [21,22]. The osteoblast lineage cells also initiate the bone remodeling
cycle by recruiting osteoclasts, which resorb damaged bone [23,24]. Osteoclasts differentiate
from myeloid precursors, primarily under the influence of macrophage colony stimulating fac-
tor (MCSF) and receptor activator of nuclear factor κB ligand (RANKL) that are produced by
the osteoblast lineage [25]. The bone remodeling cycle is balanced by regulated activity of oste-
oblasts and osteoclasts to adapt to changing mechanical and gravitational demands on the
bone [13,23].
Microgravity leads to a dysregulation of the activity between osteoblasts and osteoclasts,
leading to bone degradation [26–28]. Very little is known about the combined effects of micro-
gravity and radiation on bone, as the vast majority of publications using ground-based models
examine only one factor in isolation [3,29,30]. One potential mechanism suggested for the dis-
ruption of bone homeostasis in spaceflight includes disregulation of inflammatory cytokines
such as interleukin-6 (IL-6) [31–34], where ground-based experiments have shown increased
activity of this inflammatory pathway [26,28,35]. Similar alterations in inflammatory signals
are also seen in disuse osteoporosis [8–10] and radiation exposure [36–38].
The gp130 family of cytokines, which include IL-6, leukemia inhibitory factor (LIF), and
oncostatin M (OSM), are an important group of factors with broad effects in human bone
health and disease [39]. IL-6 signals through a complex comprised of the IL-6 receptor α sub-
unit (IL-6Rα) and a homodimer of GP130. LIF signals through a complex of GP130 and the
LIF receptor α subunit (LIFRα) [39]. OSM signals through either the LIFRα—GP130 dimer or
a dimer of GP130 and the OSM receptor ß subunit (OSMRß). All of the major cell types in
bone express some combination of GP130 cytokines and their receptors [39], and OSM has
been shown to induce IL-6 secretion by osteoblasts [40]. IL-6 has been shown to promote
both mineralization and demineralization by stimulating osteoblast differentiation [41]
and activation of osteoclasts, respectively [41,42,43]. Perception of OSM has been colored by
the role of its better-known relative IL-6. Indeed, OSM has been shown in cell culture to pro-
mote osteoclastogenesis by inducing osteoblast RANKL expression and reducing expression of
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osteoprotegerin [44–47]. However, it has also been shown that OSM promotes differentiation
and activation of osteoblasts, mineral formation, and represses the expression of sclerostin
[40,48–51]. In vivo data are complicated and suggest that some effects are species-specific [52].
Clearly, many details of the action of OSM in bone remain to be illuminated, as it is unclear
whether OSM causes net bone formation or destruction.
OSM is known to act directly on osteoblasts and indirectly on osteoclasts, and changes in
OSM action could account for many of the effects of microgravity on bone. Defining a connec-
tion amongst OSM, osteoblast activity, and radiation response would contribute to our under-
standing of OSM in bone. In this study, we examined the actions of OSM on gp130 signaling
and osteoblast activity in a model of simulated microgravity with and without radiation. Our
model system used the MC3T3-E1 mouse pre-osteoblast cell line, which has been shown to re-
capitulate important actions of OSM seen in primary cells [49,53,54]. Our results support the
hypothesis that simulated microgravity conditions along with radiation alter the action of
OSM signaling in osteoblasts. Specifically, OSM and microgravity both increased the produc-
tion of the inflammatory cytokine IL-6 in the MC3T3-E1 osteoblastic cell lines. Furthermore,
radiation in combination with microgravity also increased IL-6 production in the cell lines.
Materials and Methods
Cell Culture
The MC3T3-E1 subclone 4 mouse pre-osteoblast cell line [55] and the UMR-106 rat osteosar-
coma cell line were obtained directly from the American Type Culture Collection (Rockville,
MD). MC3T3-E1 cells were maintained in MEM (Life Technologies, Grand Island, NY) sup-
plemented to make α-MEM without ascorbic acid. All supplement components were from
Sigma-Aldrich (St. Louis, MO). UMR-106 were maintained in DMEM (Hyclone, Logan, UT).
All culture media were supplemented with 10% fetal bovine serum and 100 U/mL each of peni-
cillin and streptomycin. These supplements were obtained from Hyclone (Logan, UT). Cells
were maintained at 37°C, 5% carbon dioxide, and 95% humidity.
Microcarrier Culture
Cytopore 2 macroporous cellulose microcarriers were purchased from GE Healthcare (Pitts-
burgh, PA). Microcarriers were hydrated in phosphate buffered saline (PBS) at 20 mg/mL and
autoclaved for 20 min at 121°C. Microcarriers were rinsed twice in sterile PBS then transferred
to culture medium for at least 16 h prior to seeding cells.
To seed the microcarriers, MC3T3-E1 cells were grown to confluence, trypsinized, and sus-
pended in culture medium with microcarriers in a tissue culture flask. Concentration of cells
during seeding was 50,000 cells/mL and 5 mg microcarriers/mL. The mixture was agitated by
gentle pipetting every 20 min for 3 h and then adjusted to 2 mg/mL. After seeding microcar-
riers were incubated as above. Microcarriers were agitated each morning and afternoon. Ap-
proximately one-half the medium was replaced every three to four days. Experiments were
initiated on the seventh day after seeding.
Osteogenic Differentiation and Cytokine Stimulation
To induce osteogenic differentiation, MC3T3-E1 cells were transferred to standard α-MEM
(Life Technologies) supplemented with an additional 50 μg/mL ascorbic acid and 5 mM phos-
phate buffer at pH 7.4. Mineralization medium was also supplemented as above. Cells cultured
on microcarriers had supernatant medium removed and replaced with differentiation medium
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with mixing 3 times. To induce OSM signaling, culture medium was supplemented with
25 ng/mL recombinant mouse OSM (R&D Systems).
Rotary Cell Culture System (RCCS)
Cells were cultured on Cytopore-2 cellulose microcarriers for use in the NASA-developed Ro-
tary Cell Culture System (RCCS). This rotating wall vessel (RWV) type bioreactor models mi-
crogravity through gravitational vector averaging and low shear stress [56,57]. The Rotary Cell
Culture System (RCCS) and 10-mL high aspect ratio vessels (HARVs) were purchased from
Synthecon (Houston, TX). The HARV rotates around a horizontal axis so that medium and
microcarriers undergo solid body rotation, which averages the gravitational vector experienced
by cells to near zero. For Cytopore 2 microcarriers, a rotational speed of 18 rpm was found to
be optimal by visual inspection. Oxygenation occurs through a gas-permeable membrane, pre-
venting the formation of bubbles and ensuring smooth rotation for the microcarriers.
Modeled microgravity experiments lasted 7 days. At 12 h, 48 h, 96 h, and 7 days, samples
were collected for analysis. After ensuring uniform suspension of the microcarriers, a portion
of the medium was retained so that the microcarriers would be evenly divided among the sam-
ples. The remaining microcarriers were returned to the HARV along with fresh medium
matching the experimental condition. As controls at normal gravity, microcarriers were cul-
tured in tissue culture flasks at identical concentrations and volumes to RCCS in the incubator
at 37°C and 5% CO2, as described in previous studies involving microgravity [58–60]. Subse-
quent samples were collected by the same procedure.
Radiation
MC3T3-E1 cells were prepared on Cytopore 2 microcarriers as above. Approximately 18 h
prior to irradiation, cells were transferred to a sterile 50 ml conical tube at a concentration of 2
mg Cytopore per mL. This concentration provided excess culture medium. The tubes were
then packed in an insulated, pre-warmed box with a 2 L bottle of water at 37° C and shipped
overnight to our collaborator Dr. Jeffrey Willey. Tubes were exposed to 1 Gy at 364 rad/s from
a 137Cs source. Tubes were repacked and return shipped overnight. Controls were subjected to
a sham irradiation procedure. Upon return, cells were immediately transferred to mineraliza-
tion medium and modeled microgravity or control conditions. Samples were collected as de-
scribed above at 12 h, 48 h, 96 h, and 7 days.
Semi-Quantitative Reverse Transcription-Polymerase Chain Reaction
(RT-PCR)
Microcarriers were allowed to settle in a conical tube and the supernatant medium was aspirat-
ed. RNA was extracted using 1 mL RNA-STAT 60 (Tel-test Friendswood, TX) for each 1–2 mg
microcarriers. After a 20-min incubation, chloroform (200 μL/1 mL of RNA-STAT 60) was
added followed by vortexing for 10 seconds and centrifugation at 12,000 rpm. The upper
aqueous layer was transferred to a new tube containing isopropanol (0.5 mL/1 mL of RNA
STAT60), followed by vortexing for 10 seconds and incubation on ice for 15 min. The mixture
was centrifuged at 12,000 rpm and the supernatant discarded. The pellet was washed with 1
mL of 75% ethanol and centrifuged at 12,000 rpm, and then the supernatant discarded. The
RNA was allowed to air-dry in a sterile environment and resuspended with nuclease-free
water.
cDNA was generated from this RNA using a commercially available reverse transcriptase
kit (Applied Biosystems) per manufacturer instructions. The cDNA generated from the reverse
transcription reaction was used in a 25 μL PCR reaction containing 2.5 μL of 10x PCR buffer,
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2.5mM dNTPs, 10 mM primers, 5U GoTaq polymerase, (Promega, Madison, WI) and 2 μL
cDNA. Amplifications were carried out as follows: initial denaturation at 95°C for 2 min, fol-
lowed by the indicated number of cycles of 95°C for 1 min, annealing temperature for 1 min,
72°C for 1 min, then a final extension of 72°C for 10 min. Primer pairs and reaction conditions
for each target are provided in Table 1. The PCR products were electrophoresed on a 1% Tris-
Agarose gel containing 0.5 μg/mL of ethidium bromide at 80 volts for 45 min. The gels were
imaged using a Kodak Image station and exposed for 10 seconds. Band densities for all semi-
quantitative PCR were calculated using the ImageJ software (NIH) and normalized to
GAPDH. The sample size for OSM-treated cells with or without microgravity was four, and
the sample size for studies including radiation was three.
Enzyme-Linked Immunosorbent Assay
To measure secreted IL-6, conditioned medium was collected from each sample collected
above. IL-6 was quantified with the mouse IL-6 DuoSet kit from R&D Systems according to
the manufacturer’s instructions. Plates were washed with PBS at pH 7.4 containing 0.05%
Tween-20 (PBS-T) and blocked using PBS containing 1% IgG-free BSA (Jackson Immunologi-
cal West Grove, PA). The substrate used was Thermo Pierce (Rockford, IL) 1-Step Ultra TMB.
A seven point standard curve was prepared by serial dilution of the included 1000 pg/mL stan-
dard. Sample concentrations were interpolated from a 4 parameter logistic fit of the standards.
All samples and standards were assayed in duplicate. All ELISA analyses had a sample size
of three.
Alizarin Red Staining
For monolayer experiments, MC3T3-E1 cells were cultured in mineralization medium for 6 or
14 days in 12-well plate. For microcarrier experiments, a 2 mg sample was retained from each
RCCS experiment and cultured for an additional week in experimental conditions. Medium
was aspirated and the cells were washed once with PBS and then fixed in 10% formalin for
15 min. Formalin was aspirated and the cells were washed three times with deionized water.
Four hundred μL of 40 mM alizarin red (Millipore, Billerica, MA) was added to each sample.
Table 1. PCR Primers and Reaction Conditions.
Target Fwd. Primer Rev. Primer Prod. Size Temp. (°C) Cycles cDNA dilution
GAPDH ATCACTGCCACCCAGAAGAC GGTCCTCAGTGTAGCCCAAG 202 57 30 1:10
OSM AGCAAGCCTCACTTCCTGAG GTGGGCTCAGGTATCTCCAG 200 60 35 1:01
OSMRβ TAGACTGAACATATCCAACACCA TCCATGGATTGGCTCATCTGGCA 349 60 30 1:01
LIF CAGACAGACAGGTAGCATAAAG GACACAGAGACAGACAGAGA 487 60 35 1:01
LIFRα GAAAACTGTAAGGCGCTACA CCAAGTGTTTACATTGGC 483 52 35 1:01
IL-6 CCTCTGGTCTTCTGGAGTACCAT GGCATAACGCACTAGGTTTGCCG 307 55 30 1:10
IL-6Rα CCAGGTGCCCTGTCAGTATT CCGTGAACTCCTTTGACCAT 317 60 35 1:01
MCSF CGACTTCCCGTAAAGGCATAAA CAAGGAACACAGCCCAAAGA 530 60 30 1:01
RANKL GAGAGGTATTCCGATGCTTATG GGTGACCAACATCCTACTTATT 577 60 35 1:01
Osteoprotegerin AGAGTGAGGCAGGCTATT AGTAGTTTCTTCTGGTGCTATG 511 60 35 1:01
RUNX2 CCCTTCCTCTTCCCTTATCTCT GTGCTTCTGCTACCACTCTAAC 509 60 35 1:01
Osterix CTGCTTGAGGAAGAAGCTCACTA GGGGAGCAAAGTCAGATGGG 490 60 35 1:01
Collagen α1(I) AACAAGGTGACAGAGGCATAAA GCTGCGGATGTTCTCAATCT 440 60 30 1:10
Osteocalcin GACCATCTTTCTGCTCACTC TTGCACTTCCTCATCTGAAC 425 60 35 1:01
Sclerostin TTCCACCCAAATGTAAAGCCTGCG ATTTCTGGCCCTTCCACCATCTCT 366 60 35 1:01
doi:10.1371/journal.pone.0127230.t001
OSM and Bone Cells in Microgravity with Radiation
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After a 20-min incubation at room temperature, the stain was aspirated and the cells were
washed four times with deionized water.
For extraction and spectrophotometric quantification, 400 μL 10% acetic acid was added to
each well. The matrix was disrupted with a pipette tip in monolayer or trituration in microcar-
rier experiments. The sample was then transferred to (or retained in) a microcentrifuge tube
and incubated for 30 min at 85°C. Tubes were then transferred to ice for 5 min and then centri-
fuged 20 min at 16,000 x g. Ten standards were prepared by serial dilution from 4 mM alizarin
red. Samples and standards were adjusted to pH 4.2 with 10% ammonium hydroxide. One
hundred μL of each sample and standard was transferred in duplicate to a 96-well plate and the
absorbance read at 405 nm. Sample concentration was calculated by comparison to a linear
least-squares best fit of the standards.
For quantification by confocal microscopy and densitometry, a microscope slide of the sam-
ple was prepared after washing but before the extraction procedure. The sample was imaged on
a Zeiss LSM 510 Meta system combined with the Zeiss Axiovert Observer Z1 inverted micro-
scope and ZEN 2009 imaging software (Carl Zeiss, Inc., Thornwood, NY). Excitation was at
540 nm and emission was measured at 580 nm. A sample of at least 20 microcarriers was im-
aged under identical settings with intensity at 580 nm saved as 8-bit grayscale. Using the Ima-
geJ software (NIH), threshold was applied at 30/255 to eliminate background and the
integrated intensity of each image was calculated. Integrated intensity per bead was calculated
and used to represent alizarin red staining.
Statistics
RCCS experiments were analyzed using three-way analysis of variance (ANOVA) with repeat-
ed measures of each combination of the RCCS and OSM induction (corresponding to a culture
vessel) at each level of time. The RCCS with radiation experiments were analyzed using four-
way ANOVA with repeated measures of each combination of radiation, RCCS, and OSM in-
duction (corresponding to a culture vessel) at each level of time. Multiple comparisons were
conducted with Tukey's HSD test post hoc. Each response variable was treated separately. For
all comparisons, α = 0.05. In figures, bars and asterisks () indicate p< 0.05 for the indicated
main effect. Any interactions identified in the test had a p< 0.05. Calculations were performed
in the R statistical environment (R Project).
Results
OSM and RCCS synergistically induce IL-6 secretion
To assess the action of osteoblast OSM signaling in the RCCS, we first examined the transcrip-
tion of the cytokines and receptors most closely associated with OSM by semi-quantitative
RT-PCR (Fig 1A). OSM supplementation was observed to induce the transcription of OSMRß
(Fig 1B) and IL-6Rα (Fig 1C). Induction of the receptors reached its peak at 48 h and remained
stable afterward. These effects of OSM have not been previously described in osteoblasts.
RCCS had no statistically significant effect on these targets.
IL-6 was the most substantially affected of the examined transcripts (Fig 1D). Both OSM sup-
plementation and RCCS independently induced IL-6 transcription, which is consistent with
prior results [27,40]. Additionally, the combination of OSM supplementation and RCCS (hereaf-
ter OSM+RCCS) increased IL-6 transcription by more than twice what would be expected from
evenmultiplicative combination of their individual effects, reaching 70-fold by 7 d. This synergis-
tic effect has not previously been described. OSM's effect was seen as early as 12 h after treatment
and increased throughout the 7 days. The independent effect of RCCS was not observed until
48 h and remained stable afterward. The synergistic effect from OSM+RCCS was detected from
OSM and Bone Cells in Microgravity with Radiation
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48 h, along with the effect from RCCS alone. The amplification of IL-6 induction demonstrates
for the first time that RCCS does alter the effect of OSM signaling.
To ensure that the effects of OSM signaling induction and RCCS extended to the secretion
of the IL-6 protein, we tested the cell culture conditioned medium using ELISA (Fig 2). Again,
both OSM supplementation and RCCS were shown to independently and synergistically in-
duce osteoblast IL-6 production, with the effect of RCCS lagging OSM in both time and scale.
OSM alone increased secretion by as much as 200-fold over control conditions, while the ef-
fects of RCCS on mRNA and secreted protein were proportional at 48 h. The fold increase in
secreted protein was much larger than the transcriptional change. This may reflect the accumu-
lation of protein in the culture medium as IL-6 was produced at increasing rates, as well as its
sequestration after binding to extracellular matrix proteins secreted by the osteoblasts [61]. It is
Fig 1. OSM and RCCS independently and synergistically induce the transcription of IL-6.MC3T3-E1
pre-osteoblasts were cultured with OSM supplementation and RCCS for 7 days. RNA was collected at 12 h,
48 h, and 7 d. Semi-quantitative RT-PCR was conducted for the cytokines and receptors most closely
associated with OSM in osteoblasts, listed in (A) with representative images from 48 h, when effects were
seen for the largest number of targets. (B-D) Scatter plots of the densitometry results showing the mean and
standard error of the mean (SEM) for the targets with statistically significant regulation by OSM or RCCS
(arbitrary units). OSM alone induced the (B) OSMRß and (C) IL-6Rα subunits, shown at 48 h, when the
largest effect was seen. (D) IL-6 was induced independently by both OSM and RCCS. Induction by OSM
alone progressed from approximately 5-fold at 12 h to 20 fold at 7 d. Induction by RCCS was first significant
after 48 h and remained stable afterward at approximately 2-fold. The factors interacted significantly to
amplify their independent effect, inducing IL-6 transcription approximately 35-fold at 48 h and 70-fold at 7 d.
doi:10.1371/journal.pone.0127230.g001
Fig 2. OSM and RCCS independently and synergistically induce secretion of IL-6.MC3T3-E1 pre-
osteoblasts were cultured with OSM supplementation and RCCS for 7 d. IL-6 secretion was measured in
conditioned medium by ELISA; scatter plots showmean and SEM. OSM treatment induces secretion of IL-6
at all time points with a 7-fold induction at 12 h increasing to 200-fold by 7 d. A 2-fold increase in IL-6 secretion
by RCCS is significant at 7 d, but may be present earlier. The synergistic effect of OSM and RCCS on IL-6
secretion is first significant at 48 h at approximately 350-fold. It increases to approximately 500-fold at day 7.
doi:10.1371/journal.pone.0127230.g002
OSM and Bone Cells in Microgravity with Radiation
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also possible the at post-transcriptional regulatory effects account for difference. Regardless,
the interaction of RCCS and OSM is confirmed at the protein level. This supports the hypothe-
sis that microgravity alters OSM signaling in the osteoblast.
Radiation limits the effect of OSM induction on IL-6 secretion, but
enhances the effect of RCCS
The action of OSM signaling on osteoblast inflammatory factors was next examined in the con-
text of a more complete model of spaceflight including both simulated microgravity and radia-
tion typical of a solar particle event (SPE). Statistically significant interactions (p< 0.01)
between OSM signaling and these spaceflight conditions were again observed in the regulation
of IL-6 production (Fig 3). Radiation increased IL-6 expression but had no significant addition-
al effect on any other targets assessed by RT-PCR, including OSM, OSMRß, LIF, LIFRß, IL-
6Rα, MCSF, RANKL, osteoprotegerin, RUNX2, osterix, collagen α1(I), osteocalcin, and scler-
ostin (data not shown). The changes in IL-6 mRNA measured by RT-PCR were entirely re-
flected in the measurements of secreted IL-6 (Fig 3). A general increase in the concentration of
IL-6 compared to the experiments without radiation is attributed to the increase in Cytopore
microcarrier concentration from 4 mg/mL to 4.5 mg/mL, increasing the number of cells, and
the fewer time points at which samples were collected, decreasing the dilution of the condi-
tioned medium with fresh medium. Both changes were made to provide sufficient cell numbers
for the additional experimental factor. Sham irradiation control recapitulated the effects of the
RCCS-only model with its substantial synergistic increase in secretion (Fig 3A, left column),
validating the radiation procedure. As in the experiments without radiation, OSM increased
IL-6 secretion by at least 10-fold under all conditions. Consequently, to facilitate comparison
of other conditions, the results of the experiments with radiation are separated into panels
showing results without-OSM (Fig 3B) and with-OSM (Fig 3C).
Intriguingly, the effects of radiation in combination with OSM supplementation were oppo-
site of the effects of radiation alone or radiation with RCCS. Radiation alone increased IL-6 se-
cretion relative to the control at 48 h and 7 d by approximately 5-fold, confirming a response
recently reported for the first time in osteoblasts (Fig 3B) [37]. Radiation in combination with
RCCS increased the secretion of IL-6 relative to either factor alone. The scale of this increase
compared to multiplicative combination of the factors was approximately two-fold, compara-
ble to the synergistic effect seen from OSM+RCCS in absence of radiation. Contrary to these
increases in IL-6 secretion, irradiation decreased the effect of OSM supplementation at all time
points by a substantial margin, approximately 50% (Fig 3C). Finally, radiation did not change
the induction of IL-6 by OSM+RCCS except at 12 h, when all conditions respond as if RCCS
were not present. Considered together, these complicated interactions again support the action
of microgravity conditions on OSM signaling.
OSM counteracts the effect of RCCS on the RANKL: osteoprotegerin
ratio
It has been observed that IL-6 functions primarily in bone to magnify osteoclast recruitment
and activity [42,43]. OSM is also known to enhance RANKL expression and osteoclast activa-
tion [44,46,47]. To determine if microgravity conditions also interact with these actions of
OSM, we measured the transcription of the osteoblast-produced factors most important for
osteoclastogenesis: MCSF, RANKL, and osteoprotegerin (Fig 4A). We found that RANKL (Fig
4B) was upregulated by RCCS. RCCS alone also decreased the transcription of osteoprotegerin
(Fig 4C), so that the ratio of RANKL to its decoy receptor would be increased, which favors in-
creased osteoclastogenesis. In these experiments, OSM did not exert a statistically significant
OSM and Bone Cells in Microgravity with Radiation
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effect on RANKL expression, but there was a clear interaction between OSM signaling induc-
tion and RCCS. When the two were present in combination, osteoprotegerin mRNA levels in-
creased proportionally to the increase seen in RANKL, so that in this case the RANKL: OPG
ratio would be preserved. The implication is that the osteoblast recruitment of osteoclasts in
microgravity may depend on the absence of OSM signaling.
Fig 3. Radiation limits the effect of OSM induction on IL-6 secretion but enhances the effect of RCCS.
MC3T3-E1 cells were cultured in a spaceflight model combining culture in the RCCS and radiation
representative of a SPE (1 Gy at 364 rad/s from a 137Cs source). Osteoblast IL-6 secretion was measured by
ELISA and are shown as scatter plots with mean and SEM. An overview of these data is shown in (A). The
effects of OSM and RCCS on IL-6 secretion were unaffected by sham irradiation (A, left column). Under all
conditions, OSM treatment induced IL-6 secretion by at least 10-fold. Consequently, radiation and RCCS
effects are broken out into control (B) and OSM treated (C). In the absence of OSM treatment (B), irradiation
alone increased IL-6 secretion relative to sham irradiation by approximately 5-fold from 48 h on. The
combination of RCCS and radiation treatments (without OSM treatment, B) magnified the induction of IL-6
approximately 10-fold compared to RCCS treatment alone. With OSM treatment (C), irradiation without
RCCS decreased IL-6 secretion at all time points. Irradiation had no effect on the synergistic increase in IL-6
secretion seen with combined OSM induction and RCCS. For clarity, statistical results are shown only in (B)
and (C).
doi:10.1371/journal.pone.0127230.g003
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OSM and RCCS have independent and opposing effects on osteoblast
activity
To determine if the interdependence of osteoblast OSM signaling and RCCS extended to their
effects on osteoblast maturation and activity, we analyzed samples collected over the course of
a week in these conditions by semi-quantitative RT-PCR for several markers of osteoblast dif-
ferentiation and osteoid production (Fig 5A). Significant effects were found for collagen α1(I)
(Fig 5B), osteocalcin (Fig 5C), and sclerostin (Fig 5D). Independently, OSM treatment and
RCCS acted on collagen α1(I) and osteocalcin, as would be expected for these components of
osteoid and markers of middle and late osteoblast maturation. Both had mRNA levels in-
creased by OSM and decreased by RCCS. Sclerostin expression was increased by RCCS, sug-
gesting an increase in the osteocyte character of these cell cultures and consistent with evidence
that microgravity inhibits osteoblast differentiation. No significant interaction between these
factors was detected by ANOVA, which suggests that simulated microgravity does not alter the
effect of OSM on osteoblast activity.
Limitations associated with using this RCCS and Cytopore cell culture
model to measure the effects of microgravity on osteoid formation and
mineralization
The effect of OSM on the production of mineralized osteoid was also investigated. The organic
dye alizarin red specifically stains mineralization in osteoid (Fig 6A), allowing visualization of
the differences in osteoid production in cell culture. The dye can also be extracted and quanti-
fied spectrophotometrically [62]. This aided in the choice of the MC3T3-E1 cell line to study
OSM's effect in osteoblasts. The MC3T3-E1 cell line was chosen for these experiments in part
because of the clear effect OSM has on culture mineralization, whereas the UMR-106 rat osteo-
sarcoma cell line, for example, shows no effect (Fig 6B).
Fig 4. OSM counteracts the effect of RCCS on the RANKL: osteoprotegerin ratio. Semi-quantitative
RT-PCRwas used to examine the interaction of OSM and modeled microgravity on the osteoblast
transcription of MCSF, RANKL, and osteoprotegerin. (A) Representative images from samples collected after
48 h, when the most significant effects were seen for RANKL and osteoprotegerin. No changes were
detected for MCSF or with radiation for any of these targets. Significant effects when quantified by
densitometry are shown as scatter plots with mean and SEM for RANKL (B) and osteoprotegerin (C). RANKL
transcription increased under RCCS (B), without an associated increase in osteoprotegerin (C). The
combination of OSM and RCCS, however, increased osteoprotegerin proportionally to the increase in
RANKL.
doi:10.1371/journal.pone.0127230.g004
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A different approach to mineral quantification was used for MC3T3-E1 cells cultured on
Cytopore microcarriers when the extraction technique proved insufficiently sensitive. Because
alizarin red fluoresces when excited by light at 530–560 nm, staining could be visualized with
laser confocal microscopy (Fig 6C). It proved possible to quantify the staining by densitometry,
and thus mineralization, on samples of microcarriers (Fig 6D and 6F). While reproducible, the
results from this technique showed substantially higher mineralization in RCCS (Fig 6F), not at
all consistent with the known effects of spaceflight [2,3]. During staining, large quantities of what
proved to be mineralizing material were sometimes noted (Fig 6E). This material, presumed to
be osteoid, was only found in normal gravity control cultures, never in samples from the RCCS.
It appears the microcarriers must be stationary for the osteoblasts to produce mineralized oste-
oid. In the control gravity samples, the mineralized osteoid was generally disrupted and lost dur-
ing staining and washing, so that most of it could not be quantified. When the remnant
mineralized osteoid was quantified, however, it substantially exceeded the mineral found on only
the microcarriers (beads) from the same samples (Fig 6F). If mineralized osteoid could have been
preserved in the final staining, it is likely that total mineralization would have been much higher
in control gravity samples compared to RCCS conditions. From our observations, we conclude
that the RCCSmodel of microgravity, used with cotton cellulose-based Cytopore microcarrier
beads, is unable to reproduce the patterns in mineral formation seen in actual spaceflight data.
Other types of beads may need to be considered for future studies such as collagen-based, or hy-
droxyapatite-activated bacterially spun cellulose-based microcarriers or scaffolds [63].
Discussion
Understanding how microgravity disrupts osteoblast function is important for human space
exploration, as well as for patients on earth experiencing extended bed rest or disuse osteoporo-
sis. There are many uncertainties in the action of inflammatory signaling in the regulation of
Fig 5. OSM and RCCS have independent and opposing effects on osteoblast activity.Markers of
osteoblast maturation and activity were assessed by semi-quantitative RT-PCR for interactions between
OSM signaling and RCCS. Representative images at 48 h are shown (A), when the largest effects were
found. For markers affected by OSM or RCCS, the results of densitometry are shown as scatter plots with
mean and SEM (B-D). OSM supplementation induced collagen α1(I) (B) and osteocalcin (C) transcription, but
had no significant effect on sclerostin transcription (D). RCCS inhibited the transcription of collagen α1(I) and
osteocalcin, while increasing transcription of sclerostin. No significant interaction between the factors was
detected by ANOVA.
doi:10.1371/journal.pone.0127230.g005
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bone remodeling. The results presented here connect the questions of microgravity's action on
MC3T3-E1 osteoblastic cells and the function of the GP130 cytokines. In particular, they sup-
port the hypothesis that microgravity and ionizing radiation alter the function of OSM signal-
ing in osteoblasts. The pattern seen in the disruption of the effects of OSM is consistent with
the increase in osteolysis and decrease in osteogenesis seen in astronauts.
The most prominent effect of our model of simulated microgravity on osteoblast OSM sig-
naling was on GP130 signaling itself, particularly the secretion of IL-6. We described here an
increase in IL-6 secretion by RCCS and the synergistic increase by the combination of RCCS
and OSM supplementation. The increase in secretion is closely paralleled by an increase in IL-
6 mRNA. The degree of increase in IL-6 secretion cannot be explained by a simple combination
of the individual effects of RCCS and OSM. This is clear evidence that one affects the other.
One possible explanation for this is that RCCS interferes with feedback inhibition mechanisms
regulating OSM signal transduction or IL-6 secretion. Inhibition of OSM and IL-6 signaling by
suppressor of cytokine signaling (SOCS) protein is an example of an important regulatory
pathway that is known to be involved in skeletal health and could be inhibited in microgravity
[64,65]. As IL-6 acts in bone to increase the recruitment of osteoclasts [42,43], this increase in
IL-6 secretion can reasonably be expected to contribute to osteolysis in microgravity. This is
particularly significant considered alongside the data collected from astronauts suggesting that
GP130 signaling is generally altered in spaceflight and IL-6 levels increased in particular [31–
34]. While not dependent on RCCS, the observed increase in OSMRß and IL-6RαmRNA is
Fig 6. Limitations associated with using this RCCS and Cytopore cell culture model to measure the
effects of microgravity on osteoid formation andmineralization. (A) Alizarin red staining of osteoid
mineralization after culture of MC3T3-E1 cells for 6 or 14 days in mineralizing culture medium. OSM
increases production of mineralizing osteoid. (B) Quantification of the differential effect of OSM on
mineralization after 14 d in monolayer culture for the MC3T3-E1 mouse pre-osteoblast and UMR-106 rat
osteosarcoma cell lines. (C) Confocal micrograph (400x) of fluorescent alizarin red bound to mineralization in
MC3T3-E1 culture on Cytopore microcarriers for 14 d. (D) Representative confocal micrograph (50x) of
MC3T3-E1 cultured 14 d on Cytopore with mineralization stained for quantification by densitometry. (E)
Confocal micrograph (50x) of Cytopore MC3T3-E1 culture in control gravity conditions showing mineralized
osteoid. (F) Densitometry showed greater mineralization in RCCS cultures. (G) Mineralized osteoid accounts
for the majority of mineralization under control gravity conditions.
doi:10.1371/journal.pone.0127230.g006
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consistent with a positive feedback mechanism for OSM and IL-6 signaling that may be impor-
tant in understanding the general action of these cytokines on osteoblasts.
OSM's regulation of osteoblast IL-6 secretion is further complicated in a spaceflight model
that includes microgravity and radiation. Our results showed that radiation alone or in combi-
nation with RCCS increased IL-6 secretion, as did OSM treatment. Radiation in combination
with OSM, however, diminished the OSM-induced secretion by as much as half. While radia-
tion alone, as a single challenge, has historically been thought to cause a persistent reduction of
osteoblast activity, more recent studies have uncovered a more complex response that may be
driven by inflammatory-mediated processes versus cell death [66]. For example exposures to
less than 2 Gy promote osteoblast differentiation and osteoid production [67–69]. At doses
above 2 Gy, bone formation has been observed to both decrease [70–73] and increase at certain
time points [73,74]. Yumoto and colleagues have also observed that the combination of irradia-
tion with unloading may also determine the effect of ionizing radiation on osteoblast function
[75], as we observed here. Applying these observations to our data, it is reasonable that the
combined effect of OSM and radiation differs from their individual effects. It is also noteworthy
that factors other than dose can affect osteoblast response to radiation. Linear energy transfer
(LET) may be an important factor [36,76,77], which should be considered in evaluating our
model that only uses low-LET photons. The radiation from solar particle events (SPE) and ga-
lactic cosmic rays (GCR) in spaceflight has a large high-LET component [7]. While it is
thought that high-LET radiation is generally more toxic than low-LET, it has other effects such
as causing changes in epigenetic expression and differential production of miRNA levels
[78,79]. As noted, the few reports using high-LET radiation (e.g., Fe56 ions) on bone formation
and physiology show varied responses often related to dose and timing after exposure
[68,75,80,81]. Therefore, the effect of high-LET radiation on bone is still not very well under-
stood and further studies are needed to more accurately assess GCR effects on bone. As we
have shown, many factors must be considered in any attempt to understand the osteoblast re-
sponse to radiation.
In summary, OSM treatment, modeled microgravity using the RCCS, and radiation all inde-
pendently increase the secretion of IL-6. OSM has the largest and most immediate effect. RCCS
and radiation both a have more modest effect on IL-6 secretion that presents more slowly than
the effect from high levels of OSM supplementation. The difference in timing may only be ap-
parent due to the inability of our assays to detect the comparatively smaller early effects, or it
may indicate that OSM acts more directly on IL-6 transcription than RCCS or radiation. These
explanations are not mutually exclusive.
We have also described a dependence on RCCS for the action of OSM on osteoblast-mediat-
ed osteoclast recruitment. In control gravity conditions, active OSM signaling had no effect on
the RANKL: osteoprotegerin ratio. In RCCS, OSM signaling increased osteoprotegerin levels.
On its own, this is further evidence that microgravity alters the action of OSM signaling in the
osteoblast, which supports our central hypothesis. It also demonstrates that RCCS depends on
the presence or absence of other factors for its effects. By implication, the effect of microgravity
on astronauts may depend on factors that vary between individuals, such as baseline inflamma-
tory cytokine levels. It cannot be determined from these experiments how this feature of OSM
signaling in RCCS, which would oppose increased osteoclastogenesis, balances with the in-
crease in IL-6 secretion and its support of osteoclast recruitment. Although these experiments
did not support microgravity acting through OSM signaling to affect osteoblast activity and
maturation, it is worth noting that they focused on the osteoblast-committed MC3T3-E1 cell
line. OSM is known to act throughout the osteoblast lineage from uncommitted precursors to
osteocytes [51,82,83]. One can imagine that microgravity would alter the effect of OSM signal-
ing at other points in the osteoblast lineage. Our results imply that inflammatory signaling
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pathways must be considered in understanding the action of microgravity on
osteoclast activity.
It is worthwhile to consider the inability of this system to model changes in osteoid produc-
tion and mineralization in microgravity. Mineralized osteoid could not form in RCCS, most
likely due to the microcarriers' constant motion and shear forces. The ability of the osteoblasts
to move beyond the microcarrier beads appears to have been critical for the organization and
amount of osteoid they produced. That ability to move and interact in a larger space may also
have been critical in successfully modeling the decrease in osteoblast activity seen in micrograv-
ity. Also Cytopore beads are manufactured from a plant source using cotton as a base for the
cellulose beads and may not promote accurate model of mineralization. Other types of micro-
carriers can also be used that may help model bone environment more accurately such as colla-
gen-based microcarriers or more bio-compatible bacterially-spun cellulose scaffolds [63].
Overall, microgravity and radiation act independently of OSM to increase osteoblast-medi-
ated production of RANKL and IL-6 and suppression of osteoprotegerin, where these effects
may cause increased osteoclast activity. Meanwhile, microgravity inhibits the activity of
MC3T3-E1 osteoblasts, which when combined with effects on osteoclasts through signaling
may both promote osteolysis and inhibit replacement with new bone. Additionally, micrograv-
ity synergizes with OSM to increase IL-6 production further without any balancing effect on
osteoblast activation, so that the overall effect of OSM on osteoblasts in microgravity may pro-
mote bone loss. The effects of OSMmay therefore contribute to the uncoupling of bone forma-
tion and resorption that occurs during spaceflight. This interpretation of our results is
summarized graphically in Fig 7. The role that osteoblasts play in bone is complex, where
many effects depend on the spatial and temporal interaction of many different cells. It is diffi-
cult to predict which features of that complexity will be important for a given question, in bone
or anywhere in biology. The most valuable contribution of this work may be pointing to
GP130 signaling as a feature that must be included in a complete picture of osteoblast activity
in space.
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